American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

Committee Resources

Committee Meeting Minutes

October 29, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

July 14, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

April 28, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

April 14, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

March 25, 2020 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.
RSS
12

Committee-Related News

AHPA submits comments to FDA proposed rule on traceability for “certain foods”

March 1, 2021: Association requests appropriate scope for “herbs” listing, consideration of a supplemental proposed rule

In comments submitted to the U.S. Food and Drug Administration (FDA) on Monday, AHPA has requested significant revisions and clarifications to a proposed rule that would establish new, additional traceability recordkeeping requirements for categories of foods on a newly published “Food Traceability List.” (FTL)

AHPA requests adequate federal funding for USPS

July 1, 2020: AHPA members depend on the Postal Service to transport herbal products

AHPA President Michael McGuffin sent a letter to Congressional leaders in the U.S. House and Senate to request adequate federal funding be included in a fourth COVID-19 relief package to ensure the financial viability and continued operations of the United States Postal Service (USPS).

Oregon adopts temporary rule prohibiting unsubstantiated claims that goods prevent, treat, diagnose, or mitigate COVID-19 related conditions

April 17, 2020: AHPA has been working with other trade organizations to seek withdrawal of a much-broader proposed rule that the OR DOJ published for comment late last year and in amended form in March 2020.

The Oregon Department of Justice (OR DOJ) has temporarily adopted a rule declaring it “unfair and deceptive” (and thus unlawful) to represent that any product “will prevent, treat, diagnose, mitigate, or cure coronavirus, COVID-19 or a related condition, without first having competent and reliable scientific evidence upon which to base a reasonable belief in the truth of the representation.” The temporary rule is effective for six months, until October 14, 2020.
Adverse event reporting tells the story of dietary supplement safety

Adverse event reporting tells the story of dietary supplement safety

March 3, 2020: FDA AER data often lacks fields that may prevent misinterpretation, including FDA’s assessment of causation

Washington, D.C. — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data. Dr. Kingston is an expert on clinical toxicology and pharmacology, poison control, product post-market surveillance, and drug and dietary supplement safety.
RSS